세계의 무균 조제 약국 시장 보고서(2025년)

Sterile compounding pharmacies are specialized facilities that prepare personalized medications in a sterile environment, tailoring medication to the specific needs of individuals. This approach proves beneficial for various reasons, including patient intolerance to standard commercial doses or specific components. Compounding in a sterile environment enables patients to receive drugs with customized doses and formulations, excluding non-essential and undesirable components.

The primary products in sterile compounding pharmacies include injectables, nasal, ocular, and otic formulations. Injectables are pharmacological substances or drugs intended for injection into the body using a needle and syringe. Sterile compounding pharmacies offer production services such as customization, patient-specific dosing, and elimination of intolerable components, ensuring the safety, sterility, and quality of injectable medications tailored to individual patient requirements. These injectables find application in various therapeutic areas, including hormone replacement therapy, pain management, dermatology, oncology, hematology, dental, among others. Administration routes include intravenous, intramuscular, and subcutaneous, catering to diverse end-users such as adults, pediatrics, geriatrics, and veterinary applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The sterile compounding pharmacies market research report is one of a series of new reports from The Business Research Company that provides sterile compounding pharmacies market statistics, including sterile compounding pharmacies industry global market size, regional shares, competitors with a sterile compounding pharmacies market share, detailed sterile compounding pharmacies market segments, market trends and opportunities, and any further data you may need to thrive in the sterile compounding pharmacies industry. This sterile compounding pharmacies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sterile compounding pharmacies market size has grown strongly in recent years. It will grow from $5.34 billion in 2024 to $5.62 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to patient safety concerns, a shift towards personalized medicine, home infusion therapies, clinical trials and investigational drugs, and support for rare diseases.

The sterile compounding pharmacies market size is expected to see strong growth in the next few years. It will grow to $7.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to a rise in chronic diseases, aging population and healthcare needs, drug shortages and supply chain disruptions, advancements in precision medicine, increased focus on patient-centric care. Major trends in the forecast period include automation and robotics integration, stringent regulatory compliance, personalized medicine and specialized compounds, shift to outsourced compounding services, and technological advances in aseptic techniques.

The forecast of 6.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. specialty pharmacies by driving up the cost of isolator workstations and sterile vial-filling machines sourced from Italy and the Netherlands, exacerbating 503B facility operational costs and limiting customized medication access. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in the demand for personalized medicine is poised to propel the growth of the sterile compounding pharmacies market in the future. Personalized medicine, which utilizes information about an individual's genes or proteins to prevent, diagnose, or treat diseases, is facilitated by sterile compounding pharmacies. These pharmacies play a crucial role in delivering personalized medications in a sterile environment, tailoring drugs based on individual needs to enhance treatment outcomes, patient satisfaction, and therapy adherence. Notably, the approval of 12 new personalized medicines in 2022, as reported by the Personalized Medicine Coalition, underscores the increasing prominence of personalized medicine. Hence, the escalating demand for personalized medicine is a driving force behind the growth of the sterile compounding pharmacies market.

The increasing aging population is significantly driving the growth of the sterile compounding pharmacies market in the future. An aging population refers to a scenario where the proportion of older individuals within a community rises over time. Sterile compounding pharmacies are essential in providing tailored medication solutions for this demographic by preparing medications in liquid, topical, or suppository forms, which facilitates easier administration. For example, in October 2022, the World Health Organization, a specialized health agency based in the US, reported that by 2030, 1 in 6 people globally will be 60 or older, and this figure will double to 2.1 billion individuals in this age group by 2050. Consequently, the growing aging population is expected to propel the sterile compounding pharmacies market.

The adoption of robotic automation emerges as a prominent trend in the sterile compounding pharmacies market. Major companies in the market focus on leveraging robotic automation to enhance their market position. For example, in March 2023, Omnicell Inc., a healthcare technology company, introduced the IVX Station, a robotic compounding technology designed for safe and efficient sterile compounding preparations using automation. This technology features an automated compounding process in an ISO Class 5 environment, incorporating continuous monitoring of temperature, humidity, and particles. The IVX Station prioritizes safety with advanced vision systems, gravimetric verification, auto-labeling, and automated application of tamper-evident syringe caps. Moreover, it offers scalability through a cloud-based formulation library, ensuring access to the latest authorized formulations for manufacturers.

Major companies in the sterile compounding pharmacies market adopt strategic acquisition and collaboration as part of their growth strategy. A strategic acquisition involves one company purchasing another or its assets to achieve long-term strategic objectives. In October 2023, Sharp, a pharmaceutical packaging company, acquired Berkshire Sterile Manufacturing (BSM) to enhance its capabilities in offering fully integrated small-to-medium scale sterile injectable services. The acquisition complements Sharp's services with BSM's expertise in sterile manufacturing and Contract Development and Manufacturing Organization (CDMO) services.

In January 2022, Revelation Pharma Corp, a compounding pharmacy company, acquired Innovation Compounding Inc. for an undisclosed amount. This strategic acquisition aligns with Revelation's goal of establishing a national network of 503A and 503B compounding pharmacies. Innovation Compounding Inc., a 503A compounding pharmacy, provides sterile and non-sterile compounded pharmaceuticals to patients in 49 states.

Major companies operating in the sterile compounding pharmacies market include B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter's House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.

North America was the dominant region in the sterile compounding pharmacies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sterile compounding pharmacies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sterile compounding pharmacies market consists of sales of injectable drugs and infusions created in an environment free from microorganisms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sterile Compounding Pharmacies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sterile compounding pharmacies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sterile compounding pharmacies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sterile compounding pharmacies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Injectables; Nasal; Ocular; Otic
• 2) By Therapeutic Area: Hormone Replacement Therapy; Pain Management; Dermatology; Oncology; Hematology; Dental; Other Therapeutic Areas
• 3) By Route Of Administrations: Intravenous; Intramuscular; Subcutaneous
• 4) By End-Users: Adults; Pediatrics; Geriatrics; Veterinary
• Subsegments:
• 1) By Injectables: Sterile Solutions; Sterile Suspensions; Sterile Powders For Reconstitution
• 2) By Nasal: Nasal Sprays; Nasal Solutions; Nasal Gels
• 3) By Ocular: Ophthalmic Solutions; Ophthalmic Suspensions; Ocular Inserts
• 4) By Otic: Otic Solutions; Otic Suspensions; Otic Gels
• Companies Mentioned: B. Braun SE; PharMerica Corporation; Fagron Group BV; QuVa Pharma Inc.; NewCo Pharma GmbH; Medisca; PharMEDium Healthcare Holdings Inc.; Central Admixture Pharmacy Services (CAPS); SandsRx LLC; LeeSar Inc.; Avella Specialty Pharmacy; Stokes Pharmacy Inc.; Imprimis Pharmaceuticals Inc.; Wells Pharmacy Network LLC; McGuff Compounding Pharmacy Services Inc.; Potter's House Apothecary Inc.; Pharos Innovations LLC; Triangle Compounding Pharmacy Inc.; Valor Compounding Pharmacy Inc.; Pace Pharmacy; PenCol Specialty Pharmacy LLC; Pavilion Compounding Pharmacy LLC; Olympia Pharmacy; MedisourceRx; Stat RX Pharmacy; Rx3 Compounding Pharmacy; Atlas Pharmaceuticals Co. Ltd.; ReNue Rx; Premier Pharmacy Labs Inc.; Absolute Pharmacy Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sterile Compounding Pharmacies Market Characteristics

3. Sterile Compounding Pharmacies Market Trends And Strategies

4. Sterile Compounding Pharmacies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sterile Compounding Pharmacies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sterile Compounding Pharmacies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sterile Compounding Pharmacies Market Growth Rate Analysis
• 5.4. Global Sterile Compounding Pharmacies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sterile Compounding Pharmacies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sterile Compounding Pharmacies Total Addressable Market (TAM)

6. Sterile Compounding Pharmacies Market Segmentation

• 6.1. Global Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectables
• Nasal
• Ocular
• Otic
• 6.2. Global Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormone Replacement Therapy
• Pain Management
• Dermatology
• Oncology
• Hematology
• Dental
• Other Therapeutic Areas
• 6.3. Global Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous
• Intramuscular
• Subcutaneous
• 6.4. Global Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adults
• Pediatrics
• Geriatrics
• Veterinary
• 6.5. Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterile Solutions
• Sterile Suspensions
• Sterile Powders For Reconstitution
• 6.6. Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Nasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nasal Sprays
• Nasal Solutions
• Nasal Gels
• 6.7. Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Ocular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ophthalmic Solutions
• Ophthalmic Suspensions
• Ocular Inserts
• 6.8. Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Otic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Otic Solutions
• Otic Suspensions
• Otic Gels

7. Sterile Compounding Pharmacies Market Regional And Country Analysis

• 7.1. Global Sterile Compounding Pharmacies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sterile Compounding Pharmacies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sterile Compounding Pharmacies Market

• 8.1. Asia-Pacific Sterile Compounding Pharmacies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sterile Compounding Pharmacies Market

• 9.1. China Sterile Compounding Pharmacies Market Overview
• 9.2. China Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sterile Compounding Pharmacies Market

• 10.1. India Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sterile Compounding Pharmacies Market

• 11.1. Japan Sterile Compounding Pharmacies Market Overview
• 11.2. Japan Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sterile Compounding Pharmacies Market

• 12.1. Australia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sterile Compounding Pharmacies Market

• 13.1. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sterile Compounding Pharmacies Market

• 14.1. South Korea Sterile Compounding Pharmacies Market Overview
• 14.2. South Korea Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sterile Compounding Pharmacies Market

• 15.1. Western Europe Sterile Compounding Pharmacies Market Overview
• 15.2. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sterile Compounding Pharmacies Market

• 16.1. UK Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sterile Compounding Pharmacies Market

• 17.1. Germany Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sterile Compounding Pharmacies Market

• 18.1. France Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sterile Compounding Pharmacies Market

• 19.1. Italy Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sterile Compounding Pharmacies Market

• 20.1. Spain Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sterile Compounding Pharmacies Market

• 21.1. Eastern Europe Sterile Compounding Pharmacies Market Overview
• 21.2. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sterile Compounding Pharmacies Market

• 22.1. Russia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sterile Compounding Pharmacies Market

• 23.1. North America Sterile Compounding Pharmacies Market Overview
• 23.2. North America Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sterile Compounding Pharmacies Market

• 24.1. USA Sterile Compounding Pharmacies Market Overview
• 24.2. USA Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sterile Compounding Pharmacies Market

• 25.1. Canada Sterile Compounding Pharmacies Market Overview
• 25.2. Canada Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sterile Compounding Pharmacies Market

• 26.1. South America Sterile Compounding Pharmacies Market Overview
• 26.2. South America Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sterile Compounding Pharmacies Market

• 27.1. Brazil Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sterile Compounding Pharmacies Market

• 28.1. Middle East Sterile Compounding Pharmacies Market Overview
• 28.2. Middle East Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sterile Compounding Pharmacies Market

• 29.1. Africa Sterile Compounding Pharmacies Market Overview
• 29.2. Africa Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sterile Compounding Pharmacies Market Competitive Landscape And Company Profiles

• 30.1. Sterile Compounding Pharmacies Market Competitive Landscape
• 30.2. Sterile Compounding Pharmacies Market Company Profiles
  • 30.2.1. B. Braun SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. PharMerica Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Fagron Group BV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. QuVa Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. NewCo Pharma GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Sterile Compounding Pharmacies Market Other Major And Innovative Companies

• 31.1. Medisca
• 31.2. PharMEDium Healthcare Holdings Inc.
• 31.3. Central Admixture Pharmacy Services (CAPS)
• 31.4. SandsRx LLC
• 31.5. LeeSar Inc.
• 31.6. Avella Specialty Pharmacy
• 31.7. Stokes Pharmacy Inc.
• 31.8. Imprimis Pharmaceuticals Inc.
• 31.9. Wells Pharmacy Network LLC
• 31.10. McGuff Compounding Pharmacy Services Inc.
• 31.11. Potter's House Apothecary Inc.
• 31.12. Pharos Innovations LLC
• 31.13. Triangle Compounding Pharmacy Inc.
• 31.14. Valor Compounding Pharmacy Inc.
• 31.15. Pace Pharmacy

32. Global Sterile Compounding Pharmacies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sterile Compounding Pharmacies Market

34. Recent Developments In The Sterile Compounding Pharmacies Market

35. Sterile Compounding Pharmacies Market High Potential Countries, Segments and Strategies

• 35.1 Sterile Compounding Pharmacies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sterile Compounding Pharmacies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sterile Compounding Pharmacies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer